“I ’v e
d i s c o v e r e d
a o n c e - a - y e a r o s t e o p o r o s is
t r e a t m e n t , f o r
a n
o n - t h e - g o w o m a n l i k e
m e .”
“M y n a m e is M e g .
I 'v e g o t osteoporosis.
I'm e v e ry b o d y 'sfa v o rite cooky
I lo v e m y exercise class a n d I lea rn
a ll th e h o ttest dance m o v e s f r o m
m y g ra n d d a u g h ter.
I m a n o n - th e - g o w o m a n '.'
D isco ver
- —**
R e c l a s t
(zoledronic acid) injection
5 m g/ioo mL for infusion
Reclast is a prescription medication that treats
postmenopausal osteoporosis.
•
One intravenous (IV) dose a year, along with
daily calcium and vitamin D, helps strengthen
bones and protect them from fracture
•
No other osteoporosis treatment is approved
to help protect from fracture in more places:
hip, spine, even other bones
• A once-a-year IV given by a nurse or doctor
that takes at least
1 5
minutes
Ask your doctor if Reclast is right for you.
1
-
8 6 6
-Reclast
• www.rcclast.com
Important information:
You should not take Reclast. if you’re on Zometa® (zoledronic acid) Injection as it contains the same
ingredient: if you have low blood calcium, kidney problems, or are allergic to Reclast or Zometa. Or you're
pregnant, plan to become pregnant or nursing.
It’s important to drink fluids before getting Reclast to help prevent kidney problems. The most common side
effects are flu-like symptoms, fever, muscle or joint pain and headache. Tell your doctor if you have dental
problems because rarely, problems with the jaw have been reported with Reclast. Discuss all medicines
you’re taking, including prescription and non-prescription, vitamins and herbal supplements. If you develop
severe bone, joint or muscle pain, numbness, tingling or muscle spasms, contact your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwalch or call 1-800-FDA-1088.
If you don't have prescription coverage and can’t afford your medicines, log onto www.pap.novartis.com or call 1-800-245-5356.
Reclast. Y e a r-lo n g p ro te c tio n f o r o n -th e -g o w om en.
Please see next page for important product information.
©2008 Novartis
Printed in U.S.A. 5/08
RST-800299